Erratum to: Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Medical oncology - 32(2015), 11 vom: 26. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abdel-Rahman, Omar [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: |
|---|
| doi: |
10.1007/s12032-015-0688-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR023892331 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR023892331 | ||
| 003 | DE-627 | ||
| 005 | 20230519163644.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12032-015-0688-6 |2 doi | |
| 035 | |a (DE-627)SPR023892331 | ||
| 035 | |a (SPR)s12032-015-0688-6-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.81 |2 bkl | ||
| 100 | 1 | |a Abdel-Rahman, Omar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Erratum to: Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Abdel-Wahab, Manal |e verfasserin |4 aut | |
| 700 | 1 | |a Shaker, Mohammed |e verfasserin |4 aut | |
| 700 | 1 | |a Abdel-Wahab, Sherif |e verfasserin |4 aut | |
| 700 | 1 | |a Elbassiony, Mohammed |e verfasserin |4 aut | |
| 700 | 1 | |a Ellithy, Mahmoud |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medical oncology |d New York, NY : Springer, 1984 |g 32(2015), 11 vom: 26. Sept. |w (DE-627)SPR023865016 |w (DE-600)2008172-8 |x 1559-131X |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2015 |g number:11 |g day:26 |g month:09 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12032-015-0688-6 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 44.81 |q ASE |
| 951 | |a AR | ||
| 952 | |d 32 |j 2015 |e 11 |b 26 |c 09 | ||